Abstract:IL‐17A, the effector cytokine of T helper (Th) 17 cells, plays a crucial role in the pathogenesis of psoriasis. The Notch1 and PI3K/AKT signaling pathways are implicated in Th17 cell differentiation and IL‐17A production. The present study aimed to evaluate the regulatory effect of the Notch1/hairy and enhancer of split 1 (Hes1)‐PTEN/AKT/IL‐17A feedback loop on Th17 cell differentiation via the PI3K/AKT inhibitor LY294002 in a mouse model of psoriasis. Mice were randomly divided into 3 groups: a control group, a model group [5% imiquimod (IMQ)‐induced group] and an intervention group (5% IMQ‐induced plus LY294002‐treated group). Skin structural characteristics were recorded and evaluated by hematoxylin and eosin staining. The weights of the spleens and inguinal lymph nodes were measured. Th17 cell percentage, as well as the mRNA and protein expression levels of Notch1, Notch1 intracellular domain (NICD1), Hes1, PTEN, AKT, phosphorylated (p)‐AKT, mTOR complex 1 (mTORC1), p‐mTORC1, S6 kinase (S6K)1, S6K2 and IL‐17A were detected in skin samples of the three experimental groups. Additionally, splenic mononuclear cells from model mice were treated by 10 and 50 μM LY294002 to further evaluate its regulatory effect on Notch1/Hes1‐PTEN/AKT/IL‐17A feedback loop. Increased Th17 cell percentage, increased expression of Notch1, NICD1, Hes1, AKT, p‐AKT, mTORC1, p‐mTORC1, S6K1, S6K2 and IL‐17A, and decreased PTEN levels were observed in model mice alongside marked psoriasis‐like skin inflammation, splenomegaly and lymphadenopathy. LY294002 treatment significantly alleviated the severity of psoriasis‐like skin inflammation in the intervention mice, attenuated the degree of epidermal hyperplasia and dermal inflammatory cell infiltration, and mitigated splenomegaly and lymphadenopathy. In addition, LY294002 treatment reversed the increased Th17 cell percentage, as well as the increased expression of Notch1, NICD1, Hes1, AKT, p‐AKT, mTORC1, p‐mTORC1, S6K1, S6K2 and IL‐17A, and the decreased expression of PTEN. In vitro study from 5% IMQ‐induced mouse splenic mononuclear cells presented that high dose of LY294002 exerted more obviously regulatory effect on Notch1/Hes1‐PTEN/AKT/IL‐17A feedback loop. The current findings suggested that the Notch1/Hes1‐PTEN/AKT/IL‐17A feedback loop regulates Th17 cell differentiation within the disease environment of psoriasis. Blocking the Notch1/Hes1‐PTEN/AKT/IL‐17A feedback loop may thus be a potential therapeutic method for management of psoriatic inflammation.

Tonic type 2 immunity is a critical tissue checkpoint controlling autoimmunity in the skin

Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?

Prominent Role of Type 2 Immunity in Skin Diseases: Beyond Atopic Dermatitis

The imbalance between Type 17 T-cells and regulatory immune cell subsets in psoriasis vulgaris

Keratinocytes under Fire of Proinflammatory Cytokines: Bona Fide Innate Immune Cells Involved in the Physiopathology of Chronic Atopic Dermatitis and Psoriasis

Metabolic coordination between skin epithelium and type 17 immunity sustains chronic skin inflammation

Type I Immune Response Induces Keratinocyte Necroptosis and is Associated with Interface Dermatitis.

Skin-resident T Cells Contribute to the Dynamic Disease Manifestations of Psoriasis

Skin-resident innate lymphoid cells converge on a pathogenic effector state

IKK2 controls the inflammatory potential of tissue-resident regulatory T cells in a murine gain of function model

Immunity to commensal skin fungi promotes psoriasiform skin inflammation

Type 2 Innate Lymphoid Cells and Skin Fibrosis in a Murine Model of Atopic Dermatitis-Like Skin Inflammation

IRAK2 Has a Critical Role in Promoting Feed-Forward Amplification of Epidermal Inflammatory Responses

Homeostatic IL-13 in healthy skin directs dendritic cell differentiation to promote TH2 and inhibit TH17 cell polarization

A Critical Role of the IL-1β-IL-1R Signaling Pathway in Skin Inflammation and Psoriasis Pathogenesis.

Genetic control directed toward spontaneous IFN-alpha/IFN-beta responses and downstream IFN-gamma expression influences the pathogenesis of a murine psoriasis-like skin disease

High-dimensional profiling of regulatory T cells in psoriasis reveals an impaired skin-trafficking property

Notch1/Hes1‐PTEN/AKT/IL‐17A feedback loop regulates Th17 cell differentiation in mouse psoriasis‐like skin inflammation

Skin immunity and its dysregulation in psoriasis.

Unveiling multifaceted roles of myeloid innate immune cells in the pathogenesis of psoriasis

Skin barrier-inflammatory pathway is a driver of the psoriasis-atopic dermatitis transition